title: Parathyroid localization with high-resolution ultrasound and technetium Tc 99m sestamibi.
abstract: OBJECTIVE
  High-resolution ultrasound and technetium Tc 99m sestamibi scanning can be used for preoperative localization of abnormal parathyroid glands in patients with hyperparathyroidism.
  
  
  METHODS
  Ultrasound and sestamibi scanning were performed in patients undergoing neck exploration for hyperparathyroidism. If the 2 scans agreed in identifying a single adenoma, and surgery confirmed the location of a single adenoma and an ipsilateral normal gland, a unilateral exploration was performed.
  
  
  METHODS
  University tertiary care center.
  
  
  METHODS
  Sixty-one consecutive patients undergoing surgery for hyperparathyroidism from September 1, 1994, through September 30, 1997.
  
  
  METHODS
  High-resolution ultrasound was performed in 59 patients and sestamibi scanning in 58 patients; all patients underwent neck exploration by a single surgeon.
  
  
  METHODS
  The results of preoperative ultrasound and sestamibi scanning were compared with operative and histological findings.
  
  
  RESULTS
  All patients were cured of hypercalcemia. Specificity of ultrasound and sestamibi scanning was 98% and 99%, respectively; however, their sensitivity was only 57% and 54%, respectively. Both imaging modalities had lower sensitivities in the setting of multigland disease. If both imaging studies were considered as a single test, sensitivity for imaging in patients with primary hyperparathyroidism reached 78%. Our localization protocol allowed a unilateral approach in 43% of patients (23 of 53).
  
  
  CONCLUSIONS
  These results confirm the value of preoperative localization in patients with hyperparathyroidism. A unilateral approach can be used with a high degree of success in cases when ultrasound and sestamibi scanning agree in the identification of a single adenoma confirmed by surgical exploration with the identification of a normal ipsilateral gland.
authors.affiliation: Department of Surgery, Stanford University, Calif. 94305-5494, USA.
authors.forename: G P
authors.initials: GP
authors.lastname: Purcell
authors.forename: F M
authors.initials: FM
authors.lastname: Dirbas
authors.forename: R B
authors.initials: RB
authors.lastname: Jeffrey
authors.forename: M J
authors.initials: MJ
authors.lastname: Lane
authors.forename: T
authors.initials: T
authors.lastname: Desser
authors.forename: I R
authors.initials: IR
authors.lastname: McDougall
authors.forename: R J
authors.initials: RJ
authors.lastname: Weigel
mesh_terms: D000236:Adenoma / Q000150:complications / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000000981:diagnostic imaging / Q000209:etiology; D008297:Male; D008875:Middle Aged; D010282:Parathyroid Neoplasms / Q000150:complications / Q000000981:diagnostic imaging*; D011300:Preoperative Care; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D012680:Sensitivity and Specificity; D017256:Technetium Tc 99m Sestamibi; D014463:Ultrasonography
chemical_list: D019275:Radiopharmaceuticals; D017256:Technetium Tc 99m Sestamibi